Skip to main content

Allergy Program News

Experts from CHOP’s Allergy Program are recognized as global leaders in the management of allergic conditions and have helped formulate many of the national guidelines used by physicians around the world.

Contact us

Alumni Notes, Fall 2023

Dec 5, 2023

The CHOP Alumni Organization created a new recognition, the Patrick Pasquariello Service Award. See who was honored with the inaugural award.

News at CHOP: Fall 2023

Dec 5, 2023

Stay up to date on the latest research and staff news from Children’s Hospital of Philadelphia.

FDA Approves Two Gene Therapies for Sickle Cell Disease

Dec 8, 2023

The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease  in patients 12 years and older with recurrent vaso-occlusive crises (VOCs). 

Jump back to top